SMA therapies (a LinkAGE webinar)
1:10:17
Reading a genomic test report
12:43
Genomics in Midwifery
2:28
3 жыл бұрын
Let's talk about... Uncertainty
1:46
Let's talk about... Possible results
2:37
Genomic sequencing and Covid-19
4:30
Пікірлер
@NoxIgnisEclipse
@NoxIgnisEclipse 16 күн бұрын
This was so well-explained, I feel much more confident now.
@CometChaser-q9z
@CometChaser-q9z 17 күн бұрын
useful
@vichekahouy-h2p
@vichekahouy-h2p 20 күн бұрын
thank you
@aryamanjha9380
@aryamanjha9380 Ай бұрын
I had to watch an ad just to like the video
@zomvies
@zomvies Ай бұрын
Horribly explained, dont ever make yt videos again
@Eva-vx3cg
@Eva-vx3cg Ай бұрын
You have a mistake in your video. The one minute mark, you show DNA as having mirror image strands. Actually, DNA is anti-parallel, so one strand is opposite in relation to the other. It would be good to fix! Otherwise, really good.
@HiMy-p7o
@HiMy-p7o Ай бұрын
Tysm
@bumonthecorner13
@bumonthecorner13 Ай бұрын
this didnt help at all just got me more confused like at 0:40 when it says the first wo show a child who has inherited the father's x chromosome and so will be a girl..... why does that guarantee that.
@GenomicsEducation
@GenomicsEducation 28 күн бұрын
Thanks for reaching out. To directly answer your question on why we say the child will be female when inheriting the X-chromosome from her dad, this is because males have both ‘X’ and ‘Y’ chromosomes (XY), while females have two ‘X’ chromosomes (XX). Therefore, should the dad provide an ‘X’ chromosome at conception, it’s expected that the baby will be born XX (one X from the dad and the other X from the mum) and so will be female. Should the dad provide a ‘Y’ chromosome at conception, it’s expected that the baby will be born XY (the Y from the dad and the X from the mum) and so will be male. Still uncertain? For a different take on this topic, see this BBC Bitesize article on sex determination: www.bbc.co.uk/bitesize/guides/zcdfmsg/revision/5 Thanks again for your comment and hope the above helps.
@colinrussell6373
@colinrussell6373 Ай бұрын
Very helpful, thanks! 😃
@inkmetalpanda
@inkmetalpanda 2 ай бұрын
Thank you for sharing your story! We need to push help from the professionals a lot more because kick shouldn't have been a factor esp since this was considered a male dominant disease. Sending healing thoughts and strength to you and your family from an affected Fabry Female ❤
@aqsasafdar2111
@aqsasafdar2111 2 ай бұрын
IAM 7 BUT I CAN LEARN IT LIE 🌸🎶❤️‍🔥
@NicholasSleeis
@NicholasSleeis 2 ай бұрын
Shine light on how one with Silver-Russell Syndrome can beat the plight of severe hip/ leg/ ankle pain that keeps one awake most nights
@HajaJallow-e5f
@HajaJallow-e5f 3 ай бұрын
thank you sir I have to do my home work ❤❤❤❤❤❤❤❤❤❤❤
@karinajones1121
@karinajones1121 3 ай бұрын
Thank you for this.
@weemissile
@weemissile 3 ай бұрын
Please ask Dr Patterson to get a better microphone. I can barely understand him.
@93prodbyaj
@93prodbyaj 3 ай бұрын
Cant understand this bri ish yute
@ThinkingInTheAir
@ThinkingInTheAir 4 ай бұрын
please stop playing such dramatic music in every video it's really annoying just leave the music out and say the words. All of these videos are like this..I want to hear dais without music
@vamsiraj4660
@vamsiraj4660 4 ай бұрын
Concept is cleared with better explanation in shorter tenure
@patrickmoan4086
@patrickmoan4086 4 ай бұрын
Fantastic summary of the fundamentals. Much appreciated.
@hamzaothman9434
@hamzaothman9434 4 ай бұрын
where i can find the presentation slides?
@GenomicsEducation
@GenomicsEducation 4 ай бұрын
Hi and thank you for your query. This presentation's slides aren't available for download. Should you wish to re-visit this presentation in the future, then consider bookmarking our HPO terms explainer article, which also has this video, at: www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/the-human-phenotype-ontology
@enzopaolozavalacancho259
@enzopaolozavalacancho259 5 ай бұрын
2:28 Does the reference sequence/genome is also obtained by WGS?
@GenomicsEducation
@GenomicsEducation 4 ай бұрын
Thank you for your question. Whole genome sequencing (WGS) refers to DNA sequencing of an organism's entire genome. So technically yes, WGS was done to create the very first human reference genome, which was published in the early 2000s. (However, it was not sequenced all in one go like scientists do nowadays.) Today, scientists can compare a patient's genome to this reference genome (which has since seen updates) to help understand the genomic basis of their condition. Thank you again and we hope this helps. If you'd like to find out more, then please see our 2017 blog post which looks at the reference genome, where it came from and why it needs continuous updates: www.genomicseducation.hee.nhs.uk/blog/reference-genome-defining-human-difference/
@sidhik_778
@sidhik_778 5 ай бұрын
whoop yeh super bro❤❤
@kemalturgut9127
@kemalturgut9127 5 ай бұрын
How do computers identify which nucleotides consists of what bases and where are they located etc. ? Im begging for an answer
@GenomicsEducation
@GenomicsEducation 4 ай бұрын
Thank you for your comment. To answer your question: There are many ways to sequence DNA. How computers identify what DNA base is where depends on which way is used. In Sanger sequencing - one of the first ways invented - laboratory processing tags each base with a different fluorescent marker. The computer then looks for fluorescent signals from the DNA. For example, when the computer detects a green-fluorescent signal, it knows that there is an adenine DNA base located there. When it detects a blue-fluorescent signal, it knows that there is a guanine DNA base. In this way, the computer can ‘read’ DNA and tell us the order of bases. This is simplified explanation. For a more thorough explanation, please see this video by ClevaLab, which provides a fun look at Sanger sequencing: kzbin.info/www/bejne/jmqYZ2mvfpeWeNE We hope this helps. Thank you again for the question.
@kemalturgut9127
@kemalturgut9127 4 ай бұрын
@@GenomicsEducation this was a great explanation. Thank you. And how do fluorescent markers bind to the specific parts of the DNA to reveal where the light is coming from ? Do you make specific probes in labs and hybrid it with fluorescent molecules ? Im genuinely curious
@GenomicsEducation
@GenomicsEducation 4 ай бұрын
​@@kemalturgut9127 Thank you for your reply and question on fluorescent markers in the context of DNA sequencing. The technology is best understood visually. So, take a look at 'Sanger DNA Sequencing, From Then to Now' on ClevaLab's channel to see the whole process in an understandable way: kzbin.info/www/bejne/jmqYZ2mvfpeWeNE
@nusratafrin898
@nusratafrin898 5 ай бұрын
Thanks for sharing
@europhile2658
@europhile2658 5 ай бұрын
Is there a sample report online?
@GenomicsEducation
@GenomicsEducation 5 ай бұрын
Thank you for your query. While we don't have an example sample report to hand, you may find the information provided within our online rare disease and solid tumours courses of use. There are parts within about genomic reports, including what you might expect to see. Solid tumours course: www.futurelearn.com/courses/genomics-in-the-nhs-a-clinicians-guide-to-genomic-testing-for-cancer-solid-tumours? Rare disease course: www.futurelearn.com/courses/genomics-in-the-nhs-a-clinicians-guide-to-genomic-testing-for-cancer-solid-tumours? All our educational materials (many are free) may be found online at: www.genomicseducation.hee.nhs.uk/education/ We hope this helps and thank you for taking the time to watch our film.
@AfaanwazirKhan
@AfaanwazirKhan 6 ай бұрын
Thanks,very outstanding video
@Hehehehe7v
@Hehehehe7v 6 ай бұрын
Just one question 🙋 you guys said that data you we're talking about is in statistical format and require specialist to make that simple and explain to non experts but what if we put that machine data to an ai and ask it to simplify it to child level. I want to be bioinformatics too but I guess I am too paranoid about its replacement. Can you help me?
@GenomicsEducation
@GenomicsEducation 5 ай бұрын
Many thanks for your comment. There are several limitations in using AI to simplify complex medical problems: statistical models are inherently complex and difficult to reduce to simple terms without losing accuracy; AI struggles to understand the nuances of medical data, often leading to oversimplifications or incorrect conclusions; AI models can be biased, resulting in misleading interpretations; finally, human expertise is crucial for accurately conveying complex medical information, a task AI cannot fully replicate. We hope this provides a satisfactory answer to your question. Many thanks again and thanks also for taking the time to watch the film.
@Hehehehe7v
@Hehehehe7v 5 ай бұрын
@@GenomicsEducation that's really helpful thanks a million times for it
@akhilthota3860
@akhilthota3860 7 ай бұрын
back ground music is disturbing otherwise the video in very informative and good
@ransomndubuisinnah974
@ransomndubuisinnah974 7 ай бұрын
DNA
@ArreyNeeh
@ArreyNeeh 7 ай бұрын
Good explanation 👏
@casey-zd5mj
@casey-zd5mj 7 ай бұрын
you've been genomed
@Nexus-Otaku-A-50
@Nexus-Otaku-A-50 7 ай бұрын
Thanks for explaining 😊😊😊😊
@Suresh-sk3vu
@Suresh-sk3vu 7 ай бұрын
Super
@basic-ly
@basic-ly 8 ай бұрын
Thanks! Great video! 😇
@renzo2842
@renzo2842 8 ай бұрын
thank you, sir. I have an exam regarding this concept in two days
@sanjaisrao484
@sanjaisrao484 8 ай бұрын
Thank you, Excellent explaination
@pml1111
@pml1111 10 ай бұрын
Yes, genetics medicine is bittersweet this days. Knowledge but not treatments all the times.
@George-rq1yp
@George-rq1yp Жыл бұрын
damn, best presenter i have seen!
@childspecialist-dr.akumtos4383
@childspecialist-dr.akumtos4383 Жыл бұрын
Thank you..... excellent presentation 😊
@yungbloodas3789
@yungbloodas3789 Жыл бұрын
Thank you so very much!
@mahnoorkhan5501
@mahnoorkhan5501 Жыл бұрын
Outclass explanation.... Like it
@Saed7630
@Saed7630 Жыл бұрын
Excellent presentation!
@GenomicsEducation
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Start 04:50 Overview and webinar one recap 06:28 What are cancer mutational signatures and why are they important? 09:04 Mathematical concepts to define mutational signatures 12:38 What do mutational signatures look like (with examples)? 16:15 Extracting and checking mutational signatures 20:23 Caveats to extraction 24:10 Assigning mutational signatures to samples 29:12 Examples 33:22 Clinically relevant signatures summary table 35:22 Mutational signatures: HR deficiency 41:17 Mutational signatures: MMR deficiency 45:12 Mutational signatures: POLE dysregulation 49:05 Mutational signatures: MBD4 mutated cancers 51:03 Mutational signatures: NTHL1 loss 51:18 Mutational signatures: Biallelic MUTYH mutation 55:10 Mutational signatures: Long tandem duplicators 56:12 Mutational signatures to watch out for 57:36 Acknowledgements and Q&A
@sarahvegter790
@sarahvegter790 Жыл бұрын
What if the father has the condition and the mother is a carrier of the trait, can their daughter have the condition?
@GenomicsEducation
@GenomicsEducation Жыл бұрын
Hi and thank you for the question. Any daughter from this couple will always inherit the X chromosome with the genetic variant for the condition from her father, but she may or may not inherit the X chromosome with the genetic variant for the condition from her mother. From this couple: - for daughters, 50% will have the condition while 50% will be carriers for the condition (on average). - for sons, 50% will have the condition and 50% will not have the condition (on average).
@GenomicsEducation
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Welcome and introductions 02:05 Discovering the molecular background to Cystic Fibrosis 05:14 What is the genetics of CF? 07:49 Phenotypes seen in CF and patient prognosis 12:46 CFTR types overview 13:45 CFTR modulators and triple therapy 16:27 Ivacaftor - clinical trials, real-life data, patient experiences and costs 24:02 Double therapy - Orkambi and Symkevi outcome data, patient experiences and costs 28:15 Triple therapy - What did the Kaftrio clinical trials show? 31:53 Kaftrio is commissioned by NHS England in 2020 35:16 What are patients on Kaftrio experiencing? 38:00 The estimated Katrio cost to the NHS 40:36 Ethical and access considerations 43:13 Type-1 CFTR drug efforts - CRISPR and gene editing 45:34 Talk conclusions 46:30 Q&A and close
@GenomicsEducation
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Introductions and talk overview 01:56 What is cancer, to our genome? 07:20 How does a childhood cancer genome differ from that of an adult? 12:43 WGS, paediatric oncology and equitable access 16:22 Patient and parents' perspective and NHS service implications 20:11 100,000 genomes project and paediatric genomes 27:22 Case study 1: Treatment of a 10 year old with Wilms tumour-like genomic changes in RCC 31:09 Case study 2: 16 month old's tumour treatment decided after WGS 36:00 The 'live programme' at Cambridge 39:02 Case study 3: Baby with unknown mass achieves diagnosis 41:14 Conclusions on WGS in paediatric oncology 42:30 Wrap up and Q&A
@GenomicsEducation
@GenomicsEducation Жыл бұрын
TIMESTAMPS 00:00 Introductions and talk overview 02:20 Learing objectives 03:05 What is target validation? 03:34 What is Open Targets? 05:10 What are orphan drugs? 06:49 How are the DDD project, DICIPHER database and DDG2P database related? 08:05 Motivation behind the repurposing drugs for rare disease algorithm. 10:48 Method 13:55 Results 16:30 Analysis of data 19:49 Real world example 1 - Penttinen-type premature aging syndrome 20:31 Real world example 2 - Hyperkalaemic periodic paralysis type 1 22:38 Real world example 3 - CLOVES 25:03 The future of repurposing dugs for rare disease 26:34 Acknowledgements and wrap up 28:00 Q&A
@denizguzel1942
@denizguzel1942 Жыл бұрын
@phongvong8639
@phongvong8639 Жыл бұрын
Hi! Everybody.